SYRE - Spyre Therapeutics GAAP EPS of -$0.15 beats by $0.61
2025-11-04 17:26:47 ET
More on Spyre Therapeutics
- Intelligent Development Could Make Spyre Therapeutics Best In Show
- Spyre Therapeutics prices public offering of 14.8M shares at $18.50 to raise $275M
- Spyre Therapeutics announces public offering of common stock and pre-funded warrants
- Seeking Alpha’s Quant Rating on Spyre Therapeutics
- Historical earnings data for Spyre Therapeutics